Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 429-600-4 | CAS number: 1026988-42-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Guideline conform GLP-Study (OECD 474)
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 991
- Report date:
- 1991
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- GLP compliance:
- yes
- Type of assay:
- micronucleus assay
Test material
Reference
- Name:
- Unnamed
- Type:
- Constituent
- Details on test material:
- - Name of test material (as cited in study report): Basazol Gelb 8511
- Physical state:
- Analytical purity: 96 %
- Lot/batch No.: 6123, V. 6781
Test animals
- Species:
- mouse
- Strain:
- NMRI
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River GmbH, Wiga
- Weight at study initiation: 28.2 g
- Assigned to test groups randomly: yes
- Housing: Makrolon cages, type M I
- Diet: standarized pellet foof ad libitum:
- Water ad libitum:
- Acclimation period: about one week
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20 - 24 °C
- Humidity (%): 30 - 70 %
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- - Vehicle(s)/solvent(s) used: Aqua dest.
- Amount of vehicle (if gavage or dermal): all animals received a volume of 10 ml/kg body weight - Duration of treatment / exposure:
- once
- Frequency of treatment:
- single oral administration
- Post exposure period:
- 333 mg/kg 24 hours;
1000 mg/kg 24 hours
3000 mg/kg 16, 24, 48 hours
neg. controls 24 hours
pos. controls 24 hours
Doses / concentrations
- Remarks:
- Doses / Concentrations:
333, 1000 and 3000 mg /kg bw.
Basis:
analytical conc.
- No. of animals per sex per dose:
- 5 per dose
cyclophosphamide: 2 males/3 females
vincristine: 3 males/2 females - Control animals:
- yes, concurrent vehicle
- Positive control(s):
- -cyclophosphamide
- Route of administration: orally
- vincristine
-Route of administration: intraperitoneally
- Doses / concentrations: 20 mg of cyclophosphamide/kg bw; 0.15 mg vincristine /kg bw
Examinations
- Details of tissue and slide preparation:
- CRITERIA FOR DOSE SELECTION:
Male and female animals were assigned to the test groups according to a randomization plan prepared with an appropriate computer program. The dose levels were set asf ollows: In a pretest for the determination of the acute oral toxicity of 8asazol Gelb 8511 deaths were observed down to a dose of 4000 mg/kg body weight. The amount wich was survived by all animals was 3000 mg/kg body weight.Therefore, a dose of 3000 mg/kg body weight was selected as the highest dose in the present cytogenetic study.1000 mg/kg and 333 mg/kg body weight were administered as further doses.
TREATMENT AND SAMPLING TIMES ( in addition to information in specific fields):
333 mg/kg 24 hours;
1000 mg/kg 24 hours
3000 mg/kg 16, 24, 48 hours
neg. controls 24 hours
pos. controls 24 hours
DETAILS OF SLIDE PREPARATION:
The slides were stained in eosin and methylene blue solution for 5 minutes, rinsed in aqua dest. and then placed in fresh aqua dest. for 2 or 3 minutes. They were finally stained in Giemsa solution for 12 minutes. After being rinsed twice in aqua dest. and clarified in xylene, the preparations were embedded in Corbit-Balsam.
- Evaluation criteria:
- In general, 1000 polychromatic erythrocytes from each of the male and female animals of
every testgroup are evaluated and investigated for micronuclei.The normochromatic
erythrocytes (= normocytes), which occur, are also scored. The following parameters
are recorded:
- Number of polychromatic erythrocytes
- Number of polychromatic erythrocytes containing micronuclei
The increase in the number of micronuclei in polychromatic erythrocytes of treated animals
as compared with the solvent control group provides an index of a chromosome-breaking
(clastogenic) effect or of a spindle activity of the substance tested.
- Number of normochromatic erythrocytes
- Number of normochromatic erythrocytes containing micronuclei The number of micronuclei
in normochromatic erythrocytes at the early sacrifice intervals represents the situation before
test substance administration and may serve as acontrol value.
A substance-induced increase in the number of micronuclei in normocytes may be found with an increasein the duration
of the sacrifice intervals.
- Ratio of polychromatic to normochromatic erythrocytes
This ratio indicates an influence of the testsubstance specifically on the bone marrow.
- Number of small micronuclei (d < D/4) and of large micronuclei (d > D/4) (d = diameter of micronucleus,0 = cell diameter)
The size of micronuclei may give an indication on the possible mode of action of the test substance i.e. a clastogenic or a spindl
poison effect. - Statistics:
- A statistical evaluation was not necessary to perform. The number of polychromatic micronucleated erythrocytes after test substance treatment waswithin/nearly the range of the actual control value and within the historical values.
Results and discussion
Test results
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- yes
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- RESULTS OF RANGE-FINDING STUDY
- Dose range: up to 4000 mg/kg
Any other information on results incl. tables
The single oral administration of aqua dest. in a volume of 10 ml/kg body weight led to 1.8% polychromatic erythrocytes containing micronuclei after the 24-hour sacrifice interval.
After the single administration of the highest dose of 3000 mg/kg body weight, 2.0% polychromatic erythrocytes containing micronuclei were found after 16 hours and 1.6% after 24 hours and 48 hours.
In the two lower dose groups rates of micronuclei of about 2.0% (1000 mg/kg group) and 1.5% (333 mg/kg group) were detected after a sacrifice interval of 24 hours in each case.
With 21.4% the positive control substance cyclophosphamide for clastogenicity, as expected, led to a clear increase in the number of polychromatic erythrocytes containing mainly small micronuclei at a dose level of 20 mg/kg body weight.
With 46.8% the positive control vincristine for spindle poison effects also led to a clearly enhanced number of micronuclei containing polychromatic erythrocytes with the expected amount of large micronuclei, i.e. 10.6%.
Clinical examinations:
The single oral administration of the solvent in a volume of 10 ml/kg body weight was tolerated by all animals without any signs or symptoms.Doses of 3000 mg/kg and 1000 mg/kg led to irregular respiration, piloerection and squatting posture about 30minutes after test substance administration; in a few cases the general state of the animals was poor. After about 2 hours some animals had closed eyelids. 3 animals died 4 hours and 1 animal the day after treatment of 3000 mg/kg body weight. After administration of 333 mg/kg body weight only irregular respiration and piloerection were observed.The urine of the animals of all test groups was colored orange or brownish. Neither the single administration of the positive control substance cyclophosphamide in a dose of 20 mg/kg bodyweight nor that of vincristine in a dose of 0.15 mg/kg body weight caused any evident signs of toxicity.
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): negative
According to the results of the present study, there are thus no biologically relevant, significant differences in the frequency of erythrocytes containing micronuclei either between the solvent control and the 3 dose groups (3000 mg/kg, 1000 mg/kg and 333 mg/kg) or between thev arious sacrifice intervals (16, 24 and 48 hours). Thus, under the experimental conditions chosen here, the test substance Basazol Gelb 8511 has no chromosome-damaging (clastogenic) effect nor does it lead to any impairment of chromosome distribution in the course of mitosis. - Executive summary:
According to the results of the present study, the single oral administration of Basazol Gelb 8511in doses of 3000 mg/kg, 1000 mg/kg and 333 mg/kg body weight did not lead to any increase in the number of polychromatic erythrocytes containing either small or large micronuclei. The rate of micronuclei was always in the same range as that of the negative control in all dose groups and at all sacrifice intervals.
No inhibition of erythropoies is determined from the ratio of polychromatic to normochromatic erythrocytes was detected.
Thus, under the experimental conditions chosen here, the test substance Basazol Gelb 8511does not have any chromosome-damaging (clastogenic) effect, and there were no indications of any impairment of chromosome distribution in the course of mitosis.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.